BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8220935)

  • 1. Immunoassay of platelet-derived growth factor in the plasma of patients with scleroderma.
    Dunbar PR; Harrison A; Corkill MM; Neale TJ
    Br J Rheumatol; 1993 Nov; 32(11):966-71. PubMed ID: 8220935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma levels of platelet-derived growth factor (PDGF-BB + PDGF-AB) in patients with never-treated mild essential hypertension.
    Rossi E; Casali B; Regolisti G; Davoli S; Perazzoli F; Negro A; Sani C; Tumiati B; Nicoli D
    Am J Hypertens; 1998 Oct; 11(10):1239-43. PubMed ID: 9799041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transforming growth factor-beta and platelet-derived growth factor in linear scleroderma.
    Restrepo JF; Guzmán R; Rodríguez G; Iglesias A
    Biomedica; 2003 Dec; 23(4):408-15. PubMed ID: 14968919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
    Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
    J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma platelet-derived growth factor B-chain levels in cancer patients.
    Leitzel K; Bryce W; Tomita J; Manderino G; Tribby I; Thomason A; Billingsley M; Podczaski E; Harvey H; Bartholomew M
    Cancer Res; 1991 Aug; 51(16):4149-54. PubMed ID: 1868437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole decreases platelet-derived growth factor levels in human serum.
    Takehara K; Grotendorst GR; Silver R; LeRoy EC
    Arteriosclerosis; 1987; 7(2):152-8. PubMed ID: 3579723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma.
    Kahaleh MB; Osborn I; Leroy EC
    Ann Intern Med; 1982 May; 96(5):610-3. PubMed ID: 6176160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth factors in the pathogenesis of progressive systemic sclerosis].
    Altomare GF; Polenghi MM; Pigatto PD; Florita S; Finzi AF
    G Ital Dermatol Venereol; 1989 May; 124(5):187-92. PubMed ID: 2620917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of basic fibroblast growth factor and transforming growth factor-beta on the two platelet-derived growth factor receptors' expression in scleroderma and healthy human dermal fibroblasts.
    Ichiki Y; Smith E; LeRoy EC; Trojanowska M
    J Invest Dermatol; 1995 Jan; 104(1):124-7. PubMed ID: 7798629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
    Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
    J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassay of platelet-derived growth factor in the blood of patients with diabetes mellitus.
    Harrison AA; Dunbar PR; Neale TJ
    Diabetologia; 1994 Nov; 37(11):1142-6. PubMed ID: 7867886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells?
    Engström-Laurent A; Feltelius N; Hällgren R; Wasteson A
    Ann Rheum Dis; 1985 Sep; 44(9):614-20. PubMed ID: 3876080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1.
    Kikuchi K; Kadono T; Ihn H; Sato S; Igarashi A; Nakagawa H; Tamaki K; Takehara K
    J Invest Dermatol; 1995 Jul; 105(1):128-32. PubMed ID: 7615966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.
    Kurimoto M; Nishijima M; Hirashima Y; Endo S; Takaku A
    Acta Neurochir (Wien); 1995; 137(3-4):182-7. PubMed ID: 8789659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
    Takemura H; Suzuki H; Fujisawa H; Yuhara T; Akama T; Yamane K; Kashiwagi H
    J Rheumatol; 1998 Aug; 25(8):1534-9. PubMed ID: 9712097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma.
    Gay S; Jones RE; Huang GQ; Gay RE
    J Invest Dermatol; 1989 Feb; 92(2):301-3. PubMed ID: 2918236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor in vivo: levels, activity, and rate of clearance.
    Bowen-Pope DF; Malpass TW; Foster DM; Ross R
    Blood; 1984 Aug; 64(2):458-69. PubMed ID: 6331547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts.
    Yamakage A; Kikuchi K; Smith EA; LeRoy EC; Trojanowska M
    J Exp Med; 1992 May; 175(5):1227-34. PubMed ID: 1314885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic osteoarthropathy: endothelium and platelet function.
    Silveri F; De Angelis R; Argentati F; Brecciaroli D; Muti S; Cervini C
    Clin Rheumatol; 1996 Sep; 15(5):435-9. PubMed ID: 8894355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma platelet-derived factors in patients with systemic scleroderma--alterations of plasma beta-thromboglobulin and platelet factor 4 levels after vibration stress on bilateral hands].
    Maeda M; Shikano Y; Ichiki Y; Nakano I; Mori S
    Nihon Hifuka Gakkai Zasshi; 1988 Nov; 98(12):1205-9. PubMed ID: 2976432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.